Next-Generation Sequencing
BC Platforms, Euformatics, Oncompass to Develop Oncology NGS Workflows for European Hospitals
The companies have won a partially EU-funded contract from a coalition of seven hospitals to integrate, standardize, and analyze NGS data to inform clinical decision support.
MSK to Launch Trial of T-Cell Receptor Therapy Targeting Common Neoantigen With Pharma Partner
Premium
The therapy, which could potentially have tissue-agnostic use, is designed to target a public neoantigen from a mutation in the oncogenic driver gene PIK3CA.
Drugmakers Come Together Hoping to Formalize MRD as Surrogate Endpoint in AML Trials
MPAACT members will share trial data, aiming to standardize measurable residual disease as a surrogate endpoint for overall survival and speed up drug development. Â
NGeneBio Receives CE-IVD Mark for NGS-Based Cancer Panel
The firm's accompanying software analyzes companion diagnostic biomarkers such as EGFR, BRAF, KRAS, HER2, and ROS1 genes.
AmoyDx, AstraZeneca Collaborate to Develop, Commercialize Companion Diagnostic Tests
The agreement involves the codevelopment of a CDx to identify prostate cancer patients in China, the European Union, and Japan with HRR gene mutations.